Form4insider filings, from the source

SEC Form 4 · accession 0001209191-16-128875

HERON THERAPEUTICS, INC. /DE/ · HRTX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Kevin C Tang
Director · 10% Owner
Period of report
Jun 16, 2016
Accepted (ET)
Jun 20, 2016 · 8:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000818033

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Jun 16, 2016M1,250,000$3.60A6,117,530IBy LP
Common StockF1,F2Jun 16, 2016F243,639$18.47D5,873,891IBy LP
Common StockF3holding———14,347IAs Trustee
Common StockF4holding———6,941D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Warrant (Right to Buy)F2$3.60Jun 16, 2016M1,250,000DJul 1, 2011Jul 1, 2016Common Stock1,250,0000I

Explanation of responses